|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Medical Service, Section of Critical Care Medicine, North Chicago VA Medical Center and Department of Medicine, Division of Critical Care Medicine, Finch University of Health Sciences/The Chicago Medical School, North Chicago, IL.
Correspondence to: Raúl J. Gazmuri, MD, PhD, Medical Service (111), North Chicago VA Medical Center, 3001 Green Bay Rd, North Chicago, IL, 60064; e-mail: Raul.Gazmuri{at}med.va.gov
| Abstract |
|---|
|
|
|---|
Design: Controlled and randomized.
Setting: Animal laboratory.
Participants: Thirty male Sprague-Dawley rats.
Interventions: The technique for TTO was initially developed and tested in five rats. A model of ventricular fibrillation (VF) was then used to compare the effects of TTO (n = 5) with the effects of O2 delivery through an endotracheal tube as part of positive-pressure ventilation (n = 5) or through a mask without additional airway intervention (n = 5). VF was induced and left untreated for 4 min, after which chest compression and one of the three oxygenation interventions was started. Defibrillation was attempted after 6 min of chest compression. In a subsequent series, defibrillation was attempted after 10 min of chest compression in rats treated with either TTO (n = 5) or endotracheal intubation (ET; n = 5).
Measurement and results: TTO and ET secured adequate arterial PO2 during chest compression (213 ± 77 mm Hg and 154 ± 36 mm Hg; not significant), whereas the mask yielded an arterial PO2 of only 49 ± 38 mm Hg (p < 0.05). Each rat treated with TTO or ET was successfully resuscitated and survived the postresuscitation interval, but none of the rats treated with the mask survived. TTO maintained its efficacy after increased duration of chest compression.
Conclusion: TTO was as effective as conventional positive-pressure ventilation with 100% O2 for securing oxygenation, resuscitation, and short-term survival and more effective than O2 delivered through a mask.
Key Words: cardiopulmonary resuscitation intubation, intratracheal O2 rats, Sprague-Dawley trachea ventricular fibrillation
| Introduction |
|---|
|
|
|---|
Studies4 in animal models of cardiac arrest have shown that large increases in arterial PCO2 (approximately 100 mm Hg) are well tolerated and do not compromise resuscitability and survival. In contrast, decreases in arterial O2 saturation can preclude restoration of cardiac activity.5 Thus, development of strategies that could selectively focus on O2 delivery without actively pursuing CO2 elimination may prove to be effective and to obviate the need of orotracheal intubation for positive-pressure ventilation.
Previous studies6 7 in large animals have shown that continuous tracheal O2 insufflation can maintain adequate arterial PO2 for long intervals even in the absence of positive-pressure ventilation or spontaneous breathing. We reasoned that O2 delivery at constant flow through a small catheter percutaneously advanced through the cricothyroid ligament into the trachea could fulfill the requirements of being simple and effective, and obviate the need for more advanced airway intervention. We devised a method for transtracheal oxygenation (TTO) in a rat model of ventricular fibrillation (VF) and investigated its effects on gas exchange, resuscitability, and short-term survival.
| Materials and Methods |
|---|
|
|
|---|
Animal Preparation
Sprague-Dawley rats (460 to 558 g) were anesthetized by
intraperitoneal injection of sodium pentobarbital, 45 mg/kg, and
supplemented with additional doses, 10 mg/kg, at 30-min intervals. Core
temperature was monitored with a thermistor (TSD102A; BIOPAC Systems;
Santa Barbara, CA) advanced 4 cm into the rectum and maintained between
36.5°C and 37.5°C using an infrared heating lamp.
A lead II ECG was recorded through subcutaneous needles. Polyethylene catheters (PE50; Becton Dickinson; Sparks, MD) were advanced through the left femoral artery into the abdominal aorta, through the right jugular vein into the right atrium, and through the right carotid artery into the left ventricle for pressure measurement and blood sampling. Pressures were measured with reference to the midchest using disposable pressure transducers (Maxxim Medical; Athens, TX). Signals were processed using BIOPAC signal conditioners (BIOPAC Systems), sampled at 250 scans per second, and digitized using a 16-bit data acquisition board (AT-MIO-16XE-50; National Instruments; Austin, TX).
For TTO, the larynx and upper portion of the trachea were surgically exposed through a 2-cm midline incision. The cricothyroid ligament was identified, and a 21-gauge needle was advanced approximately 0.5 cm into the larynx. After aspiration of free air, a guidewire was advanced through the needle lumen into the trachea. A 3F polyurethane pediatric venous catheter (C-PMS-301-J-PED; Cook; Bloomington, IN) was then advanced over the wire and its tip positioned approximately 2 cm from the carina. The catheter was secured in place with 40 nylon surgical suture (Fig 1 ). A transtracheal O2 flow of 250 mL/min was chosen to approximately match the 15 L/min previously shown6 in 24-kg dogs to secure an arterial PO2 > 100 mm Hg.
|
|
VF was induced using a 60-Hz alternating current (range, 1.0 to 7.0 mA) delivered to the right ventricular endocardium. After 4 min of untreated VF, chest compression was started at 200 breaths/min using a pneumatically driven compressor (CJ-80623; CJ Enterprises; Tarzana, CA). The depth of compression was adjusted to achieve a coronary perfusion pressure between 22 mm Hg and 26 mm Hg. These settings had previously been shown8 11 to generate approximately 16% of baseline cardiac output and approximately 18% of baseline myocardial blood flow in successfully resuscitated rats. Oxygenation (100% O2) was started concurrently with chest compression. In the TTO group, O2 was delivered at 250 mL/min. In the endotracheal intubation (ET) group, O2 was delivered as part of positive-pressure ventilation using an electronically controlled pneumatic valve (R-481; Clippard Instrument Laboratory; Cincinnati, OH) set to provide one positive-pressure breath with a tidal volume of 3.9 mL/kg animal weight for every two compressions (100 breaths/min). This setting provided a physiologic minute volume of 390 mL/kg/min and matched the postresuscitation minute volume obtained at a respiratory rate of 60 breaths/min. In the third group, O2 was delivered at a constant flow of 500 mL/min through the mask. This flow rate was set to exceed any potential inspiratory flow during reexpansion of the chest cavity following compression.
After 6 min of chest compressions (10 min of VF), defibrillation was
attempted by delivering a maximum of two 2-J direct-current
transthoracic electrical shocks (LIFEPAK 9P; Physio-Control
Corporation; Redmond, WA). If VF persisted or an organized electrical
rhythm with a mean aortic pressure of
25 mm Hg ensued, chest
compression was resumed for an additional 30 s. This sequence of
shocks and chest compression was repeatedif neededfor a
maximum of three cycles, increasing the energy of electrical shocks to
4 J and then to 8 J. Successful resuscitation was defined as a
supraventricular rhythm with a mean aortic pressure
60 mm Hg for
5 min.
At 5 min postresuscitation, animals that had been randomized to TTO were orally intubated and the transtracheal catheter was removed. Ventilation with 100% O2 was then continued in both TTO and ET groups using a volume-controlled ventilator (model 683; Harvard Apparatus; South Natick, MA) set at a rate of 60 breaths/min and a tidal volume of 6.5 mL/kg; none of the rats that received O2 through the mask were successfully resuscitated. At 15 min postresuscitation, the O2 concentration was reduced to 50%. The animals were monitored for 2 h.
Approximately 400 µL of blood was sampled from the abdominal aorta at defined intervals for pH, PO2, and PCO2 measurements using a blood gas analyzer (Nova Stat Profile 3; Nova Biomedical; Waltham, MA) and for lactate measurements using a lactate analyzer (YSI 2300 STAT; Yellow Spring Instruments; Yellow Springs, OH). An equivalent volume of arterial blood obtained from a donor rat was infused into the right atrium.
Statistical Analysis
Statistical analysis software was used (SigmaStat 1.0 for
Windows; Jandel Scientific; San Rafael, CA). Continuous
variables were compared using one-way analysis of variance (ANOVA).
Changes over time were analyzed using one-way repeated-measures ANOVA.
Equivalent nonparametric tests were substituted when tests for
normality failed. The data are presented as mean ± SD. A value of
p < 0.05 was considered significant.
| Results |
|---|
|
|
|---|
|
|
|
An additional series was conducted to determine whether the efficacy of TTO could deteriorate after increasing the duration of chest compression to 10 min (ie, by development of atelectasis). Comparable arterial PO2 was observed with TTO (n = 5) and ET (n = 5) at 4 min (171 ± 64 mm Hg vs 184 ± 82 mm Hg; NS) and at 8 min (187 ± 55 mm Hg vs 220 ± 92 mm Hg; NS) of chest compression. The arterial PCO2 was slightly higher with TTO at 4 min (44 ± 7 mm Hg vs 27 ± 7 mm Hg; p < 0.05) but not at 8 min (36 ± 7 mm Hg vs 37 ± 8 mm Hg; NS) of chest compression. Each rat in each group was successfully defibrillated and survived 120 min (Fig 4 , Table 3 ).
|
|
| Discussion |
|---|
|
|
|---|
Oxygenation During Chest Compressions
Adequate oxygenation seems to be essential for successful cardiac
resuscitation.5
However, the time at which specific
interventions for oxygenation become necessary during the resuscitation
effort is less clear. Immediate oxygenation is essential in instances
of asphyxial arrest,12
yet several minutes may elapse
before O2 supplementation is required in
instances of dysrhythmic arrest.10
Resuscitation and
survival after out-of-hospital cardiac arrest seem to be independent of
whether mouth-to-mouth ventilation is provided during basic life
support.13
These observations suggest an
O2 reservoir composed of O2
bound to hemoglobin and O2 present in the lungs
at the time of arrest. Although such a reservoir may be partially
renewed by gasping and chest compression through a patent airway, it is
eventually depleted such that O2 supplementation
becomes necessary (ie, after 4 min of chest
compression).10
Our studies assessed the effects of TTO at the time when interventions for direct tracheal oxygenation are required. The inadequate oxygenation provided by the mask demonstrated the need for direct tracheal oxygenation during chest compression in our rat model.
Current Approach
Positive-pressure ventilation with 100% O2
delivered through an endotracheal tube is the "gold standard" for
oxygenation during cardiac resuscitation. Additional benefits include
airway protection and the option for controlled ventilation. Yet, the
crisis situation of cardiac arrest imposes technical and logistic
challenges to orotracheal intubation. For example, in adult victims of
out-of-hospital cardiac arrest, trained personnel failed to properly
place an endotracheal tube in 9% of the victims.14
Similarly, in deeply comatose patients, successful endotracheal tube
placement required one attempt in 58% of the victims, two attempts in
26%, and three attempts in 6%.15
In a recent
study16
involving 305 intubation attempts during
out-of-hospital pediatric resuscitation, the trachea was successfully
intubated in only 57% of the attempts and was complicated by mainstem
intubation in 19%, subsequent endotracheal tube dislodgment in 10%,
and inadequate tube size selection in 24%. In addition, there is
increased risk of traumatic injury to the oral cavity, pharynx,
larynx,17
and trachea,18
and inadvertent tube
placement into the esophagus.15
In addition, proper
visualization of anatomic structures during orotracheal intubation
usually requires interruption of chest compression, which in of itself
can compromise resuscitability.3
TTO as an Alternative
The present and other studies19
20
21
challenge the
need for positive-pressure ventilation during cardiac resuscitation but
emphasize the need for securing adequate oxygenation. For these
reasons, a simplified approach that focuses on oxygenation
independently of effects on CO2 elimination is
appealing. The efficacy of continuous O2 delivery
during chest compression has been independently confirmed by other
investigators, both in animal models7
and in human
victims21
of cardiac arrest. Thus, TTO could represent a
more effective alternative provided deployment is accomplished faster,
with higher success rates, and with fewer complications than with
orotracheal intubation. In addition, continuous oxygenation impresses
as probably less laborious than bag-valve ventilation allowing rescuer
efforts to be focused on other more vital resuscitation interventions.
However, TTO is not free of complications. Improper technique may cause
tracheal or esophageal wall perforation with serious mediastinal
emphysema and bleeding. It can also cause cartilage injury with
disruption of the voice apparatus.22
Another important
consideration is that the airway must be patent above the insertion
site to avoid air trapping and barotrauma.
In a recent study, housestaff officers were able to successfully place 12- to 16-gauge catheters through the cricothyroid membrane in 23 of 29 patients after multiple failed attempts to secure oxygenation by ET and bag-valve-mask ventilation.23 The catheter was used for jet ventilation and promptly reversed hypoxemia. Others24 have reported the successful placement of a transtracheal catheter under similar emergency situations and used it for tracheal ventilation with intermittent O2.
Implementation of TTO in humans would probably require placement of a 16-gauge catheter advanced through the cricothyroid membrane or the first or second intertracheal ring space.24 This size catheter would allow an O2 flow of 15 L/min, corresponding to a flow that can secure adequate oxygenation in humans during chest compression.21
CO2 Elimination
Our TTO technique was not purposely designed to remove
CO2. Yet, the arterial
PCO2 during chest compression was
practically identical to that in ET-treated rats and lower than in
mask-treated rats. Similar observations were reported in dogs and
attributed to the bellows effect of chest compression.7
In
humans, the arterial PCO2 during
chest compression was lower with continuous transtracheal
O2 insufflation than with conventional
positive-pressure ventilation.21
Because
CO2 elimination may already occur during cardiac
arrest associated with gasping25
and chest
compression,10
TTO may facilitate these processes by
securing airway patency and by promoting CO2
elimination by convection.
Clinical Implications
The perceived urgency for immediate ventilation and oxygenation
propels rescuers to initiate positive-pressure ventilation through an
unprotected airway by using mouth-to-mouth or bag-valve-mask
ventilation. This approach has been shown to increase the risk of
regurgitation with potential for aspiration of gastric
contents26
and subsequent development of
pneumonia.27
Given the presence of an O2 reservoir at the onset of dysrhythmic cardiac arrest and a time window before O2 supplementation is required, ventilatory attempts through an unprotected airway may not be necessary. TTO could be the exclusive airway intervention during chest compression. Once the catheter is secured in place, 100% O2 (or other gas mixture) could be administered at a constant flow without need of a rescuer to provide positive-pressure ventilation. The tracheal catheter could also be used for drug delivery andwith additional technical developmentperhaps incorporate capability for monitoring the expired CO2 to assess the hemodynamic efficacy of chest compression.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported in part by a VA Merit Review Grant entitled, "Myocardial Protection During Cardiac Arrest," and a start-up fund provided by the Finch University of Health Sciences/The Chicago Medical School.
Presented at the Society of Critical Care Medicine 30th Educational and Scientific Symposium and received the 2001 Emergency Medicine Specialty Award, February 1014, 2001, San Francisco, CA.
Received for publication December 6, 2000. Accepted for publication May 2, 2001.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |